CNMD insider trading
NYSE HealthcareCONMED Corp: insider trade history from SEC Form 4 filings.
About CONMED Corp
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Company website: www.conmed.com
CNMD insider activity at a glance
FilingIQ tracks 1,227 insider transactions for CNMD in filings since Jan 5, 2015. The most recent transaction is dated Sep 8, 2026.
Across the full history, 34 open-market purchases
and 256 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CNMD insider trades is 61.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CNMD Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CNMD?
- FilingIQ tracks 1,227 Form 4 insider transactions for CNMD (CONMED Corp), covering filings from Jan 5, 2015 onwards. 1 of those are dated within the last 90 days.
- Are CNMD insiders net buyers or net sellers?
- Across the full Form 4 history for CNMD, 34 transactions (3%) were open-market purchases and 256 (21%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CNMD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CNMD in?
- CONMED Corp (CNMD) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.40B.
Methodology & sources
Every CNMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.